Vistagen Therapeutics
Biotechnology
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

$73.8M

Market Cap • 11/18/2024

1998

(26 years)
Founded

2009

(15 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

South San Francisco

Headquarters • California

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions
  • ...and much more!

    Get Premium